Received: 12 March 2020
Accepted: 23 April 2020
First Online: 4 May 2020
: H.Y. has received research funding from Sanofi Pasteur, GlaxoSmithKline, Yichang HEC Changjiang Pharmaceutical Company and Shanghai Roche Pharmaceutical Company. All other authors declare no competing interests.
Free to read: This content has been made available to all.